Frontoparietal network mediates the antidepressant effects of accelerated iTBS and cTBS: TMS-EEG study

Cell Rep Med. 2025 Dec 16;6(12):102470. doi: 10.1016/j.xcrm.2025.102470. Epub 2025 Dec 3.

Abstract

Accelerated intermittent and continuous theta burst stimulation (a-iTBS and a-cTBS) show strong efficacy for treatment-resistant depression (TRD), yet their neural mechanisms remain unclear. This study uses concurrent transcranial magnetic stimulation (TMS) and electroencephalography (TMS-EEG) to examine these mechanisms in 40 TRD patients and 40 healthy controls (HCs). TRD individuals demonstrate abnormal local cortical excitability at baseline, characterized by left hypoactivity and right disinhibition. A-iTBS increases left excitability, and a-cTBS increases right inhibition, and both normalize it to the level of HCs. Network analyses reveal that a-iTBS improves current propagation to the left inferior parietal lobule (IPL), correlating with a better antidepressant effect. Contrastingly, a-cTBS induces a widespread inhibition as indicated by current propagation over parietal cortices, with the left IPL being most prominent, and this also correlates with a better antidepressant effect. These findings outline the frontoparietal circuitry in TMS antidepressant effects and provide insights for optimizing treatment efficacy. This study was registered at the Chinese Clinical Trial Registry (ChiCTR2200055320).

Keywords: TMS-EEG; inferior parietal lobule; theta burst stimulation; treatment-resistant depression.

MeSH terms

  • Adult
  • Antidepressive Agents / therapeutic use
  • Depressive Disorder, Treatment-Resistant* / physiopathology
  • Depressive Disorder, Treatment-Resistant* / therapy
  • Electroencephalography* / methods
  • Female
  • Frontal Lobe* / physiopathology
  • Humans
  • Male
  • Middle Aged
  • Nerve Net* / physiopathology
  • Parietal Lobe* / physiopathology
  • Transcranial Magnetic Stimulation* / methods

Substances

  • Antidepressive Agents